Should You Buy DexCom, Inc. (DXCM)?

Is DexCom, Inc. (NASDAQ:DXCM) a good equity to bet on right now? We like to check what the smart money thinks first before doing extensive research on a given stock. Although there have been several high profile failed hedge fund picks, the consensus picks among hedge fund investors have historically outperformed the market after adjusting for known risk attributes. It’s not surprising given that hedge funds have access to better information and more resources to predict the winners in the stock market.

DexCom, Inc. (NASDAQ:DXCM) investors should be aware of an increase in hedge fund interest lately. Our calculations also showed that DXCM isn’t among the 30 most popular stocks among hedge funds (click for Q3 rankings and see the video below for Q2 rankings).

Video: Click the image to watch our video about the top 5 most popular hedge fund stocks.

To most shareholders, hedge funds are seen as unimportant, old financial vehicles of years past. While there are over 8000 funds trading today, Our researchers hone in on the leaders of this club, around 750 funds. These investment experts shepherd the lion’s share of the smart money’s total asset base, and by keeping an eye on their inimitable picks, Insider Monkey has found various investment strategies that have historically beaten the S&P 500 index. Insider Monkey’s flagship short hedge fund strategy beat the S&P 500 short ETFs by around 20 percentage points per year since its inception in May 2014. Our portfolio of short stocks lost 27.8% since February 2017 (through November 21st) even though the market was up more than 39% during the same period. We just shared a list of 7 short targets in our latest quarterly update .

Samuel Isaly of OrbiMed Advisors

Unlike the largest US hedge funds that are convinced Dow will soar past 40,000 or

Read More Here...

Bookmark the permalink.